Simona Halep, a two-time major winner, has been suspended by the International Tennis Integrity Agency (ITIA) for a doping breach.

The Romanian reportedly tested positive for Roxadustat, a banned substance used as a blood booster.

She was tested during this year’s US Open and both her A and B samples had the presence of roxadustat, an anti-anaemia drug that stimulates the production of red blood cells similar to the effects of another prohibited substance Erythropoietin (EPO).

Simona Halep becomes the most high-profile name linked with doping in tennis since 2016 when Maria Sharapova was suspended for 15 months for the use of Meldonium. Halep, however, faces a four-year ban if found intentionally guilty of using the drug.

“Simona Halep, a 31-year-old Romanian tennis player, has been provisionally suspended under Article 7.12.1 of the 2022 Tennis Anti-Doping Programme (TADP),” the body said in a statement.

“The sample was split into A and B samples and the subsequent analysis found that the A sample contained FG-4592 (Roxadustat), which is a prohibited substance listed in the 2022 World Anti-Doping Agency (WADA)

The 2018 French Open winner and the 2019 Wimbledon winner issued a statement on the matter soon after, vowing to clear her name.

“Today begins the hardest match of my life: a fight for the truth. I have been notified that I have tested positive for a substance called Roxadustat in an extremely low quantity.”

“Throughout my whole career, the idea of cheating never even crossed my mind once, as it is totally against all the values I have been educated with. Facing such an unfair situation, I feel completely confused and betrayed.”

Halep, who has already curtailed her season to undergo surgery to fix breathing problems, cannot compete in any WTA-sanctioned events until her name is cleared.

She won two WTA titles this season including the Canadian Open.

Previous articleJuventus earns vital win over Empoli
Next articlePakistan exits FATF’s grey list after 4 years